webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-C5-N-bis(PEG2-C2-acid)

  CAS No.:   Cat No.: BADC-01879 4.5  

Mal-C5-N-bis(PEG2-C2-acid) is a maleimide-functionalized bis-PEG acid ADC linker intermediate designed for dual payload attachment and enhanced solubility in antibody-drug conjugates. Keywords: ADC linker, maleimide linker, bis-PEG linker, dual payload, bioconjugation.

Mal-C5-N-bis(PEG2-C2-acid)

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C24H38N2O11
Molecular Weight
530.57

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
3-[2-[2-[2-[2-(2-carboxyethoxy)ethoxy]ethyl-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]amino]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1=CC(=O)N(C1=O)CCCCCC(=O)N(CCOCCOCCC(=O)O)CCOCCOCCC(=O)O
InChI
InChI=1S/C24H38N2O11/c27-20(4-2-1-3-9-26-21(28)5-6-22(26)29)25(10-14-36-18-16-34-12-7-23(30)31)11-15-37-19-17-35-13-8-24(32)33/h5-6H,1-4,7-19H2,(H,30,31)(H,32,33)
InChIKey
OCGSASUSCDQIMT-UHFFFAOYSA-N

Mal-C5-N-bis(PEG2-C2-acid), a versatile linker molecule with diverse applications in biochemical and pharmaceutical fields, serves as a fundamental component in various processes.

Bioconjugation: Mal-C5-N-bis(PEG2-C2-acid) facilitates the covalent linkage of biomolecules, such as antibodies, enzymes, or peptides, to diverse substrates ranging from surfaces to drug carriers. This linker enhances the stability and solubility of the coupled entities, augmenting their efficacy in diagnostic or therapeutic settings. The incorporation of PEGylation components in the molecule not only enhances hydrophilicity but also mitigates immunogenicity, rendering it a preferred choice in pharmaceutical advancements.

Drug Delivery Systems: Mal-C5-N-bis(PEG2-C2-acid) assumes a pivotal role in the development of sophisticated drug delivery platforms. By enabling the attachment of therapeutic agents to carrier molecules like nanoparticles or liposomes, it facilitates controlled drug release and targeted delivery to specific cellular locales. This precise approach proves beneficial in enhancing drug efficacy while minimizing adverse effects associated with chemotherapeutic medications.

Surface Modification: Mal-C5-N-bis(PEG2-C2-acid) enhances the functionality of biomedical devices and implants by conjugating bioactive molecules onto their surfaces. This strategic modification not only augments biocompatibility but also alleviates biofouling, facilitating desired interactions with biological systems. Such advancements are critical in diverse applications, including sensor technology, tissue engineering, and orthopedic implant developments.

Biophysical Studies: Embraced in biophysical investigations, the linker molecule aids in the exploration of intricate protein-protein interactions and conformational alterations. By cross-linking proteins or introducing detectable labels, Mal-C5-N-bis(PEG2-C2-acid) empowers researchers to delve into dynamic biological phenomena at a molecular scale.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N3-PEG5-aldehyde | Tetrazine-PEG5-SS-amine | Alkyne-PEG5-SNAP | Mal-C5-N-bis(PEG2-C2-acid)
Send Inquiry
Verification code
Inquiry Basket